Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets

Saudi Pharmaceutical Journal

Volumn 19, Issue 1, 2011, Pages 19-27

  Sakr, Walid ^a   Alanazi, Fars ^a   Sakr, Adel ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Albuterol Sulphate; Extended release; Kollidon SR; Matrix tablets

Indexed keywords

CARBOMER; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; POLYVINYL ACETATE; POVIDONE; SALBUTAMOL SULFATE; WATER;

ARTICLE; CLINICAL EVALUATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG RELEASE; DRUG SOLUBILITY; MATRIX TABLET; TABLET PROPERTY;

EID: 78650621198     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.11.002     Document Type: Article

References (32)

1. Colombo P., Conte U., Gazzaniga A., Maggi L., Sangalli M., Peppas N., Manna A. Drug release modulation by physical restrictions of matrix swelling. Int. J. Pharm. 1990, 63:43-48.
2. Colombo P., Bettini R., Santi P., Peppas N. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. PSTT 2000, 3:198-204.
3. Corti G., Cirri M., Maestrelli F., Mennini N., Mura P. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-b-cyclodextrin. Eur. J. Pharm. Biopharm. 2008, 68:303-309.
4. Claxton A., Cramer J., Pierce C. Asystematic review of the associations between dose regimens and medications compliance. Clin. Ther. 2001, 23:1296-1310.
5. Draganoiu E., Andheria M., Sakr A. Evaluation of the new polyvinylacetate/povidone excipient for matrix sustained release dosage forms. J. Pharm. Ind. 2001, 63:624-629.
6. Dennis S., Sharp S., Vickers M., Frost C., Crompton G., Barnes P., Lee T. Regular inhaled salbutamol and asthma control: the TRUST randomized trial. Lancet 2000, 355.
7. FDA, 2000. Guidelines for Bioequivalence Studies for Different Strengths of Oral Solid Dosage Forms, February 14, 2000.
8. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52:1145-1149.
9. Hardy I., Windberg A., Neri C., Byway P., Booth S., Fitzpatrick S. Modulation of drug release kinetics from hydroxypropylmethylcellulose matrix tablets using polyvinylpyrrolidone. Int. J. Pharm. 2007, 337:246-253.
10. Kumar R., Kulkarni S., Vinod R., Sandeep H., Someshwara R., Kumar A. Design and characterization of controlled release matrix tablets of stavudine. Int. J. Pharm. Clin. Res. 2010, 2:46-50.
11. Khan G., Jiabi Z. Formulation and in vitro evaluation of ibuprofen-Carbopol® 974P NF controlled release matrix tablets III: influence of co-excipients on release rate of the drug. J. Control. Release 1998, 54:185-190.
12. Kumar S., Chandrasekar M., Gopinath R., Srinivasan R., Nanjan M., Suresh B. In vitro and in vivo studies on HPMC K-100 M matrices containing naproxen sodium. Drug Deliv. 2007, 14:163-169.
13. Kolter, K., Fraunhofer, W., Ruchatz, F., 2001. Properties of Kollidon® SR as a new excipient for sustained release dosage forms. BASF ExAct 6-5.
14. Korsmeyer R.W., Gurny R., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
15. Malaterre V., Ogorka J., Loggia N., Gurny R. Oral osmotically driven systems: 30years of development and clinical use. Eur. J. Pharm. Biopharm. 2009, 73:311-323.
16. Mandal U., Gowda V., Ghosh A., Selvan S., Solomon S., Kumar T. Formulation and optimization of sustained release matrix tablet of metformin HCl 500mg using response surface methodology. Yakugaku Zasshi 2007, 127(8):1281-1290.
17. Parojcic J., Duric Z., Jovanovic M., Ibric S. An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Deliv. 2004, 11:59-65.
18. Qazi S., Samuel N., Venkatachalam T., Uckun F. Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. Int. J. Pharm. 2003, 252:27-39.
19. Reddy R., Mutalik S., Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech 2003, 4(4). (Article 61).
20. Renz H. The role of neurotrophins in bronchial asthma. Eur. J. Pharmacol. 2001, 429:231-237.
21. Siepmann F., Eckart K., Maschke A., Kolter K., Siepmann J. Modeling drug release from PVAc/PVP matrix tablets. J. Control. Release 2010, 141:216-222.
22. Sriamornsak P., Thirawong N., Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur. J. Pharm. Biopharm. 2007, 66:435-450.
23. Sriamornsak P., Thirawong N., Weerapol Y., Nunthanid J., Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur. J. Pharm. Biopharm. 2007, 67:211-219.
24. Sweetman S.C., Martindale The Complete Drug Reference 2005, Pharmaceutical Press, London, UK. 34th ed.
25. Sánchez-Lafuente C., Furlanetto S., Fernández-Arévalo M., Alvarez-Fuentes J., Rabasco A., Faucci T., Pinzauti S., Mura P. Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design. Int. J. Pharm. 2002, 237:107-118.
26. Tapia-Albarran M., Villafuerte-Robles L. Assay of amoxicillin sustained release from matrix tablets containing different proportions of Carbopol 971P NF. Int. J. Pharm. 2004, 273:121-127.
27. Tanwar Y. Formulation and evaluation of transdermal films of salbutamol sulphate. Dhaka Univ. J. Pharm. Sci. 2005, 4:2.
28. Vyas S., Jain N., Khanna S. Formulation and performance evaluation of controlled release diclofenac tablets. J. Control. Release 1989, 10:219-223.
29. Vatsaraj N., Zia H., Needham T. Formulation and optimization of a sustained-release tablet of ketorolac tromethamine. Drug Deliv. 2002, 9:153-159.
30. Wan L., Heng P., Wong L. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system. Int. J. Pharm. 1991, 73:111-116.
31. Yuksel N., Kank A., Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 2000, 209:57-67.
32. Zahirul M., Prebeg Z., Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J. Control. Release 1999, 58:215-222.